Back to Search
Start Over
TLR9 and endogenous adjuvants of the whole blood-stage malaria vaccine.
- Source :
-
Expert review of vaccines [Expert Rev Vaccines] 2010 Jul; Vol. 9 (7), pp. 775-84. - Publication Year :
- 2010
-
Abstract
- Vaccination has been a successful tool in the protection against many infectious diseases, and recent advances in biotechnology have created new techniques and strategies to produce safe and efficacious vaccines for human use. However, developing a protective vaccine against malaria has been a challenge. In this article, we focus on an old approach with some new modifications, the so-called whole-parasite vaccination strategy against blood-stage Plasmodium falciparum, the deadliest human malarial agent. In addition, we discuss recent developments in our understanding of how the endogenous adjuvant activity in the parasites, which functions via Toll-like receptor 9, acts as a double-edged sword between protective vaccination and pathological responses against malaria infection.
Details
- Language :
- English
- ISSN :
- 1744-8395
- Volume :
- 9
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Expert review of vaccines
- Publication Type :
- Academic Journal
- Accession number :
- 20624050
- Full Text :
- https://doi.org/10.1586/erv.10.60